DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

SIKKO vs SUDARSHAN: Stock Comparison

SIKKO vs SUDARSHAN PHARMA INDUpdated 10 Aug 26, 4:08 PM ISTNSE & company filings

SIKKO shows a higher net margin, while SUDARSHAN PHARMA IND shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SIKKO leads 3; SUDARSHAN leads 4 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SIKKOSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹225 Cr
₹0 Cr
P/E RatioSUDARSHAN has the lower reading
39.93x
28.27x ✓
P/B RatioSIKKO has the lower reading
2.82x ✓
4.11x
EPSSUDARSHAN has the higher reading
₹0.07
₹0.32 ✓
Book ValueContext only
₹1.98
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 39.93x
P/B Ratio
SIKKO has a lower P/B
2.82x vs 4.11x
EPS
SUDARSHAN has higher earnings per share
₹0.32 vs ₹0.07
Revenue Growth (TTM YoY)
SUDARSHAN has faster revenue growth
0% vs -41.7%
Qtr Sales Growth
SIKKO has stronger quarterly sales growth
31.67% vs 24.4%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs 3.54%
Net Margin
SIKKO has a higher net margin
7.85% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSIKKOSUDARSHAN
SectorChemicals—
IndustryPesticides & Agrochemicals—

Price

MetricSIKKOSUDARSHAN
Live Price₹6.11₹32.71
Day Change1.33%0.03%
Volume15.76 L92,985
52-Week High₹6.25₹39.3
52-Week Low₹3.55₹31.01
Distance from 52W High-2.24%-16.77%

Valuation

MetricSIKKOSUDARSHAN
Market Cap₹225 Cr₹0 Cr
P/E Ratio39.93x28.27x
P/B Ratio2.82x4.11x
EPS₹0.07₹0.32
Book Value₹1.98₹6.14
Dividend Yield0%0%

Growth

MetricSIKKOSUDARSHAN
Revenue Growth (TTM YoY)-41.7%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth31.67%24.4%
Qtr Profit Growth3.54%38.7%

Profitability & Leverage

MetricSIKKOSUDARSHAN
ROE5.92%—
ROCE5.91%—
Net Margin7.85%0%
Operating Margin10.95%—
Debt to Equity0.14x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricSIKKOSUDARSHAN
Promoter Holding54.96%57.81%▼ 1.12 pp
FII Holding7.37%▼ 0.35 pp21.95%▲ 2.57 pp
DII Holding0%0%
Public Holding37.66%▲ 0.34 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SIKKO and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.